Amgen (AMGN) Raw Materials (2013 - 2017)

Amgen (AMGN) has reported Raw Materials for 5 consecutive years, with $237.0 million the latest figure, recorded in Q2 2017.

• In Q2 2017, Raw Materials changed N/A year-over-year to $237.0 million; the TTM figure through Jun 2017 stood at $237.0 million (changed N/A YoY), while the FY2016 annual figure was $225.0 million, up 11.94% from the prior year.
• Raw Materials came in at $237.0 million for Q2 2017 at Amgen, up from $216.0 million in the prior quarter.
• The five-year high for Raw Materials was $237.0 million in Q2 2017, with the low at $198.0 million in Q4 2014.
• Average Raw Materials over 5 years is $214.4 million, with a median of $216.5 million recorded in 2013.
• Across the five-year window, Raw Materials declined 8.76% in 2014 and advanced 11.94% in 2016, its largest moves.
• Year by year, Raw Materials stood at $217.0 million in 2013, then retreated by 8.76% to $198.0 million in 2014, then increased by 1.52% to $201.0 million in 2015, then gained by 11.94% to $225.0 million in 2016, then climbed by 5.33% to $237.0 million in 2017.
• According to Business Quant data, Raw Materials over the past three periods registered $237.0 million, $216.0 million, and $225.0 million for Q2 2017, Q1 2017, and Q4 2016 respectively.